Sanofi Partners With US Startup to Develop Coronavirus Self-Test
April 16 2020 - 8:57AM
Dow Jones News
By Cristina Roca
Sanofi SA and U.S. startup Luminostics have signed an agreement
to explore collaborating on a smartphone-based self-testing
solution for the coronavirus.
"Luminostics would contribute its proprietary technology for
consumer-diagnostics for Covid-19 testing while Sanofi would bring
its clinical research testing experience and capabilities," the
company said.
The aim is to develop a smartphone-based test that can detect
the virus with respiratory samples and deliver results in 30
minutes or less, eliminating the need for professional
administration of the tests or laboratory testing, the Paris-listed
pharmaceuticals company said.
To date, there isn't an over-the-counter self-testing solution
for the virus, the company added.
Write to Cristina Roca at cristina.roca@dowjones.com;
@_cristinaroca
(END) Dow Jones Newswires
April 16, 2020 08:42 ET (12:42 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (EU:SAN)
Historical Stock Chart
From May 2023 to May 2024
